Stock Market News

Sanofi and Regeneron's Dupixent gets FDA approval for rare skin disease

Jun 20, 2025 - 08:14
 0
Sanofi and Regeneron's Dupixent gets FDA approval for rare skin disease
Read More

Tags:

Previous Article

Deutsche Bank raises target prices, upgrades Paragon in U.K. banks sector review

Next Article

Stock of The Week: Is Melrose Industries the Next Rolls-Royce?

Related Posts

Anthropic CEO says proposed 10-year ban on state AI regulation 'too blunt' in NYT op-ed

Anthropic CEO says proposed 10-year ban on state AI reg...

Jun 5, 2025  0

EU must reduce dependency on China for rare earth magnets, says Sejourne

EU must reduce dependency on China for rare earth magne...

Jun 4, 2025  0

Taiwan completes first sea trial for domestically made submarine in defence milestone

Taiwan completes first sea trial for domestically made ...

Jun 17, 2025  0